BackJohnson Chemical Pharmaceutical Works , Ltd. Overview

Johnson Chemical Pharmaceutical Works , Ltd. Profit Margin

Latest profit margin for Johnson Chemical Pharmaceutical Works , Ltd.: 3.55% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-35.34%
↓ 404.91% YoY

As of Sep 2026

Annual Profit Margin (TTM)

3.55%
↓ 73.61% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Johnson Chemical Pharmaceutical Works , Ltd. (4747.TWO) FAQ

The latest profit margin for 4747.TWO is 3.55% as of September 2026. That compares with 13.46% in the prior-year period — down 73.6% year over year. That is below the sector sector average of 13.4%. Investors often review this figure alongside Johnson Chemical Pharmaceutical Works , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 4747.TWO's profit margin moved from 13.46% to 3.55% — a 73.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Johnson Chemical Pharmaceutical Works , Ltd.'s valuation or profitability profile.

Against its sector companies, 4747.TWO currently prints 3.55% for profit margin, while the sector average sits near 13.4%. That is roughly 73.5% below the sector mean. Large gaps often invite a closer look at Johnson Chemical Pharmaceutical Works , Ltd.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Johnson Chemical Pharmaceutical Works , Ltd. converts resources into returns. At 3.55%, 4747.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 13.46% in the prior-year period — down 73.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 4747.TWO's profit margin (3.55%), review year-over-year change from 13.46%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.